2016
DOI: 10.5582/bst.2016.01020
|View full text |Cite
|
Sign up to set email alerts
|

Nosocomial infection and its molecular mechanisms of antibiotic resistance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
53
1
7

Year Published

2017
2017
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 82 publications
(63 citation statements)
references
References 74 publications
2
53
1
7
Order By: Relevance
“…(1)(2)(3)(4). Bacteremia is caused by toxic shock in 25% to 30% of the cases and usually occurs due to disseminated intravascular coagulation.…”
Section: Introductionmentioning
confidence: 99%
“…(1)(2)(3)(4). Bacteremia is caused by toxic shock in 25% to 30% of the cases and usually occurs due to disseminated intravascular coagulation.…”
Section: Introductionmentioning
confidence: 99%
“…UTI is second commonest cause of bacterial infection in Europe [9,10], and has financial implications, which are annually estimated to 1.6 billion US $ around the world [4,11,12]. A pre-test Urinary tract infection diagnosed clinically or on dipsticks was exclusion criteria for the test.…”
Section: Discussionmentioning
confidence: 99%
“…The main mediators recognized damaged lung tumor necrosis factor alpha (TNFα), interleukin 1 (IL-1), interleukin 6 (IL-6), interleukin Relatively pneumonia, as a separate nosology, is enough publications that clearly confirm the production of interleukins, both locally and in the systemic circulation in response to lipopolysaccharide complexes microorganisms [3, 7, 18−20]. According to the scientists, determination of the level of interleukin has diagnostic value, because the concentration of cytokines in the blood adequately reflects the severity of inflammation [7,8,15,17]. However, to date there is no study of the diagnostic role of cytokines in nosocomial pneumonia against the background of TBI.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years the role of cytokines as key mediators of inflammation is widely discussed [14,15]. The main mediators recognized damaged lung tumor necrosis factor alpha (TNFα), interleukin 1 (IL-1), interleukin 6 (IL-6), interleukin Relatively pneumonia, as a separate nosology, is enough publications that clearly confirm the production of interleukins, both locally and in the systemic circulation in response to lipopolysaccharide complexes microorganisms [3, 7, 18−20].…”
Section: Introductionmentioning
confidence: 99%